Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Germany / NCT07371741
Recruiting Observational

PICS Clinic Attendance and Recovery Engagement (PICS-CARE)

NCT07371741 · tracked via the Priya Life Science Germany tracker
Sponsor
Charite University, Berlin, Germany
Phase
Observational
Started
2026-02-10
Last updated
2026-02-12

Condition(s) studied

Post-intensive Care Syndrome

Study summary

To identify relevant factors influencing attendance at appointments at the PICS outpatient clinic after intensive care treatment in order to derive targeted measures to increase the participation rate or send more targeted invitations.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients who, between January 1, 2021, and December 31, 2025: * were invited for follow-up care by the PICS outpatient clinic of the Department of Anesthesiology and Intensive Care Medicine (CCM/CVK) * were ≥18 years old at the time of the appointment. Exclusion Criteria: * none

Primary outcome measure(s)

  • Follow-up appointment — 01.01.2021- 31.12.2025
    Participation in the first scheduled follow-up appointment at the post-intensive care syndrome (PICS) outpatient clinic (binary: attended vs. did not attend) is measured by medical record review.

Trial sites (1)

FacilityCityRegionStatus
Department of Anesthesiology and Intensive Care Medicine (CCM/CVK), Charité - Universitätsmedizin Berlin Berlin Germany Recruiting

More Charite University, Berlin, Germany trials in Germany

International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020) Recruiting
Guidelines on Long-term Medical Fasting Enrolling by invitation
Yoga-based Group Intervention (YoGI) for In-patients With Schizophrenia Spectrum Disorders Recruiting
Oxytocin-Augmented Group Psychotherapy for Patients With Schizophrenia - an Oxytocin-dose Comparison Recruiting
Microbiome in Atopic Dermatitis Under Systemic Therapy Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07371741 on ClinicalTrials.gov ↗ ← All trials in Germany